Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/18/2018
Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clini...
1/18/2018
Xbrane, CR Pharma Sign Letter of Intent for Lucentis Biosimilar in Chi...
1/18/2018
Suven Granted A Patent in China for NCEs Targeting Neuro Disorders
1/18/2018
Eisai Completes Construction of OSD Production Facility in China
1/18/2018
New Opportunities in Emerging Markets
1/17/2018
Amarin Announces Commencement of VASCEPA Clinical Development in Mainl...
1/17/2018
Innovent eyes IPO Later This Year, Possibly in the U.S.
1/17/2018
First Chronic HepB Patient Dosed in China in Transgene's Phase 1 Trial...
1/17/2018
China's Medical Representative Registration System: Action Items for P...
1/17/2018
3SBio Licenses Mainland China Rights of Toray's Antipruritic Agent TRK...
1/16/2018
Clinical Trials Registered on the CDE Platform Rebound to a New Peak i...
1/16/2018
Data Snapshot: Overseas Out-licensing Deals of Novel Drugs Developed i...
1/16/2018
Data Snapshot: 41 Domestic Pharma Companies Launching A-Share IPOs in ...
1/15/2018
Overview of Chinese Drug Approvals in 2017
1/15/2018
Type 1 Diabetes on the Rise in China, Most New Cases in Adults
1/15/2018
CFDA Releases List of Newly Approved Professional Journals Approved fo...
1/15/2018
CDE Publishes Notice for Office Move
1/12/2018
BeiGene and Mirati Announce Exclusive License Agreement for Sitravatin...
1/12/2018
Hengrui and Arcutis Announce Partnership for Novel Immune-Mediated Der...
1/12/2018
Ferring and the Chinese Academy of Sciences Collaborate to Advance Res...
1/11/2018
China's Recent Development on Granting Biological Sequence Claims
1/11/2018
CFDA Seeks Comments on the Amendments of Administrative Measures for D...
1/11/2018
Recent Executive Moves
1/11/2018
Ten Contemporary Chinese Biopharma Industry Predictions in 2018
1/11/2018
Fosun's Wanbang Pharma and Bial Enter Exclusive Licensing Agreement fo...
1/10/2018
Data Snapshot: Chinese Hospital Consumption of Cholesterol-Reduction D...
1/10/2018
Indigenously-developed Class 1 New Chemical Drugs Approved in China 20...
1/10/2018
CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat in 2017
1/10/2018
Numerous Provinces Expand Disease Group-Based BMI Payment Scheme at th...
1/9/2018
Sinobioway Sunterra Biotech to Initiate Trial of Two AB-CAR-T Candidat...
Page:
282
/
720
Total number of articles:
21580
:
[First]
[<<]
[280]
[281]
[282]
[283]
[284]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit